Turkish Journal of Medical Sciences
Volume 52

Number 6

Article 32

1-1-2022

Frailty in community-dwelling older adults: reliability and validity
of the Turkish version of the Gérontopôle frailty screening tool
SERDAR CEYLAN
MERVE GÜNER OYTUN
ARZU OKYAR BAŞ
MELTEM KOCA
BURCU BALAM DOĞU

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
CEYLAN, SERDAR; OYTUN, MERVE GÜNER; BAŞ, ARZU OKYAR; KOCA, MELTEM; DOĞU, BURCU BALAM;
HALİL, MELTEM GÜLHAN; CANKURTARAN, MUSTAFA; and BALCI, CAFER (2022) "Frailty in communitydwelling older adults: reliability and validity of the Turkish version of the Gérontopôle frailty screening
tool," Turkish Journal of Medical Sciences: Vol. 52: No. 6, Article 32. https://doi.org/10.55730/
1300-0144.5549
Available at: https://journals.tubitak.gov.tr/medical/vol52/iss6/32

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Frailty in community-dwelling older adults: reliability and validity of the Turkish
version of the Gérontopôle frailty screening tool
Authors
SERDAR CEYLAN, MERVE GÜNER OYTUN, ARZU OKYAR BAŞ, MELTEM KOCA, BURCU BALAM DOĞU,
MELTEM GÜLHAN HALİL, MUSTAFA CANKURTARAN, and CAFER BALCI

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol52/iss6/32

Turkish Journal of Medical Sciences
http://journals.tubitak.gov.tr/medical/

Research Article

Turk J Med Sci
(2022) 52: 2004-2010
© TÜBİTAK
doi:10.55730/1300-0144.5549

Frailty in community-dwelling older adults: reliability and validity of the Turkish version
of the Gérontopôle frailty screening tool
Serdar CEYLAN*, Merve GÜNER OYTUN, Arzu OKYAR BAŞ, Meltem KOCA, Burcu Balam DOĞU,
Meltem Gülhan HALİL, Mustafa CANKURTARAN, Cafer BALCI
Division of Geriatrics, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
Received: 25.04.2022

Accepted/Published Online: 26.06.2022

Final Version: 21.12.2022

Background/aim: Recognizing frailty had a great importance in countries with an increasing geriatric population. The study aims to
evaluate the reliability and validation of the Gérontopôle frailty screening tool (GFST), which was developed to screen frailty in the
community-dwelling older adults, for the Turkish population.
Materials and methods: In this crosssectional study, participants who applied to the geriatrics outpatient clinic of a university
hospital were included. Comprehensive geriatric assessments of all patients were performed. The validity of the GFST was tested by its
concordance with the FRAIL scale. Test-retest and interrater reliability analyses were made.
Results: Ninety-six patients were included in the study. Sixty-one and five-tenths percent (n = 59) of them are females. The median age
was 72.0 (IQR: 10.0). There was a moderate concordance between the GFST and the FRAIL scale (Cohen’s kappa: 0.566, p < 0.001). The
Gérontopôle frailty screening tool interrater and retest reliabilities were excellent (Cohen’s kappa: 0.814, p < 0.001 and 1.0, p < 0.001;
respectively). The sensitivity of the GFST determined according to the FRAIL scale is 69.39%, the specificity is 86.36%, the positive
predictive value is 85.00%, and the negative predictive value is 71.70%.
Conclusion: The Gérontopôle frailty screening tool, which can be used by all healthcare professionals, is a valid and reliable tool for the
Turkish geriatric population.
Key words: Community, frailty, older adults, Turkish population

1. Introduction
Frailty is a clinical condition that decreases the response
to stressors with the decline in physiological reserves
and accordingly increases the predisposition to negative
clinical outcomes [1, 2]. With the rise in life expectancy,
the number of individuals living with frailty also increases
[3]. According to the screening tool used, the prevalence
of older adults living with frailty changes between 4.0%
and 59.1% [4]. The increasing number of individuals
living with frailty is becoming an important public health
problem [5]. Along with increasing complicated health
conditions, there is an increase in health expenditures. For
these reasons, identifying the patient living with frailty
and taking precautions are essential [6]. Physicians, who
provide primary health care services, are the first and most
frequently encountered physician group for the patients.
It is important for these physicians to recognize patients
living with frailty and refer them to a frailty center after
implementing appropriate interventions [7].

Many frailty screening tools have been developed and
there is no gold standard tool to identify frailty [8]. Many
of these are complex to implement in primary health care.
The frailty screening tools to be used in primary health
care should be as reliable and simple as possible to detect
frailty [9]. The Gérontopôle frailty screening tool (GFST)
is one of the tools developed following these criteria
[10]. The Gérontopôle frailty screening tool, which was
developed by the Gérontopôle of the Toulouse University
Hospital, has been made available to general practitioners.
After the comprehensive geriatric assessment, necessary
interventions are made to the patients for frailty. Ninetyfive and two-tenths percent of patients referred by general
practitioners using GFST were found to be prefrail or frail
according to the FRIED frailty phenotype [10].
Recognizing frailty is of paramount importance in
countries with an increasing geriatric population. There is
a need for easy-to-apply, valid and reliable screening tools
to facilitate the recognition of frailty. The study aims to
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evaluate the reliability and validation of the GFST in the
Turkish population.
2. Materials and methods
2.1. Participants
Patients who were admitted to the geriatric outpatient
clinic of a university hospital between 01.12.2021 and
31.01.2022 were included in the study. Inclusion criteria for
the study were 65 years and older, consent to be included in
the study, Katz index of independence in activities of daily
living score (ADL) ≥5, and no acute illness. Demographic
characteristics, chronic diseases, and medications were
recorded. Within the scope of the comprehensive geriatric
evaluation, Katz ADL [11], Lawton-Brody instrumental
activities of daily living scale [12], mininutritional
assessment-short form [13], minimental state examination
[14], geriatric depression scale-15 [15], timed up and go
test [16], SARC-F [17], 4-meter gait speed test1 and grip
strength2 measurement were performed. The medical,
social, psychological, and cognitive information required
for frailty screening scales were obtained. Multimorbidity
was defined as the presence of ≥2 chronic diseases [18].
2.2. Study tool
The Gérontopôle frailty screening tool is a scale developed
for the use of general practitioners to screen frailty in
individuals aged 65 and over, without the presence of
acute disease and disability [19]. The Gérontopôle frailty
screening tool consists of three stages. In the first stage,
patients are evaluated for Katz ADL. Those who score less
than five do not need to proceed to the questionnaire stage.
In the second stage, there are six questions to be answered
by the physician about the patient. These questions are
“does your patient live alone, has your patient involuntarily
lost weight in the last 3 months, has your patient been
more fatigued in the last three months, has your patient
experienced increased mobility difficulties in the last
three months, has your patient complained of memory
problems, does your patient present slow gait speed (i.e.
>4 s to walk 4 m). The answer options are yes, no, or do
not know. When at least one of these questions is answered
“yes”, the third stage of the test is passed. At this stage,
there is the question(s) to be answered by the physician
again. They are answered with yes or no. First, “do you
think your patient is frail” question needs to be answered.
If this question is answered “yes”, the second question is “is
your patient willing to be assessed for his/her frailty status
at a future frailty clinic”. The test is ended by answering
this question as yes or no. Some patients were retested
for reliability by performing a second evaluation by the

same physician two weeks after the initial evaluation with
the GFST. In addition, some patients were evaluated by a
physician in another room to test their interrater reliability.
2.3. Translation
The translation and cultural adaptation were made
according to the recommendations of the ISPOR Task
Force [20]. To validate the language, first of all, the GFST
was translated from English to Turkish by native Turkishspeaking physicians who are experts in translation
and can speak fluent English. All authors agreed on the
Turkish translation. After the translation control was
done, the Turkish version of the test was translated back
into English by two native English speaker academicians
who did not know the original. Thus, language validation
was performed with the “forward-backward translation”
method. Finally, the test was administered to older adults
living in the community by physicians to assess the cultural
adaptation.
2.4. Reference tools
The reference frailty scale was the FRAIL scale which
consists of 5 domains. It was developed by the Geriatric
Advisory Panel of the International Academy of Nutrition
and Aging as a frailty scale that is easy to use, takes
minimum duration, and can be used by all healthcare
professionals. It can be completed without the need for
any tools or tests. As a result of the questioning of fatigue,
resistance, ambulation, illnesses, and loss of weight, a
decision is made about the frailty of the patient. For fatigue,
“how much of the time during the past 4 weeks did you feel
tired” question is asked to the patient. One of the following
answers is requested: “1 = all of the time, 2 = most of the
time, 3 = some of the time, 4 = a little of the time, 5 = none
of the time”. Those who choose answers 1 or 2 get 1 point.
Other options are 0 points. For resistance, a “yes” or “no”
answer is required to the question “by yourself and not
using aids, do you have any difficulty walking up 10 steps
without resting”. Answering “yes” to these two questions
is 1 point. To learn about illnesses, the patient is asked
whether he has “hypertension, diabetes, cancer (other than
a minor skin cancer), chronic lung disease, heart attack,
congestive heart failure, angina, asthma, arthritis, stroke,
and kidney disease”. If he has five or more illnesses, he gets
1 point. For weight loss, the current weight of the patient
is compared with the weight 1 year ago. The percentage of
weight loss, if any, is calculated. More than 5% weight loss
is 1 point. Zero points are evaluated as robust, 1–2 points
as prefrail, and 3 or more points as frail [21]. Turkish
reliability and validity were done by Hymabaccus et al. in
2017 [22].

Comprehensive Geriatric Assessment Toolkit. Gait Speed Test. Resources for the Comprehensive Geriatric Assessment based Proactive and Personalised Primary Care of the Elderly [online]. Website: https://www.cgakit.com/fr-1-gait-speed-test [accessed 31 December 2021].
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Katz ADL is a tool that consists of 6 items and is used
to evaluate the disability of the patient. Items are bathing,
mobility, eating, dressing, continence, and toileting. Four
or fewer points represent physical disability [23]. Validity
and reliability for Turkish older adults have been proven
by the study conducted by Arık et al. [11].
2.5. Ethical approval
The study protocol was approved by the local ethics
committee of Hacettepe University Faculty of Medicine
(project number: GO/21/1312, decision number: 2022/0239).
2.6. Statistical analysis
The sample size was calculated using the two rater kappa
statistics [24] by providing 90% power to determine the
correct kappa when two categories according to the FRAIL
scale robust and prefrail/frail frequencies in Turkey [22]
were 0.42 and 0.58, respectively. The significance value was
accepted as 0.05.
Statistical analysis was performed using SPSS 24.0.
Categorical variables were expressed as numbers and
percentages, numerical variables were expressed as mean
and standard deviation or median and interquartile range
according to the normal distribution situation. To evaluate
the construct validity of the GFST, the FRAIL scale was
accepted as the reference tool. Cohen’s kappa was used to
evaluate the assessment agreement between robust and
frail categories. The FRAIL scale was classified as robust
and prefrail/frail when looking at its concordance with the
GFST. Cohen’s kappa was also used to investigate interrater
and retest reliabilities. Sensitivity, selectivity, positive and
negative predictive values were calculated. p-value of <0.05
was accepted as statistically significant.
3. Results
Ninety-six patients were included in the study. Sixty-one
and five-tenths percent (n = 59) of them were female.
The median age was 72.0 (IQR: 10.0). While 61 (63.5%)
patients were married, 22 (22.9%) patients were illiterate.
The mean body mass index was 29.19 ± 5.76. The number
of patients with multimorbidity was 67 (69.8%). The most
common geriatric syndromes were polypharmacy with a
prevalence of 52.1% (n = 50) and urinary incontinence
with a prevalence of 40.6% (n = 39). The median score of
the FRAIL scale is 1.0 (IQR: 2.0). In the classification made
according to the score obtained, 44 patients (45.8%) were
robust, 29 patients were prefrail (30.2%) and 23 patients
(24.0%) were frail. Characteristics, chronic diseases,
comprehensive geriatric assessment results, and frailty
status were given in Table 1.
When we evaluated the concordance of the GFST
and the FRAIL scale, there was a moderate concordance

(Cohen’s kappa: 0.566, p < 0.001). The GFST interrater and
retest reliabilities were excellent (Cohen’s kappa: 0.814, p <
0.001 and 1.0, p < 0.001, respectively) (Table 2).
The sensitivity of the GFST determined according to
the reference scale was 69.39%, the specificity was 86.36%,
the positive predictive value was 85.00%, and the negative
predictive value was 71.70%. When we examine the
likelihood ratios, it was calculated as 5.55 for positive and
0.35 for negative.
4. Discussion
The study was conducted to demonstrate the validity and
reliability of the Gérontopôle frailty screening tool in the
Turkish geriatric population. As a result of the evaluation
made by taking the FRAIL scale as a reference, there was a
moderate concordance between the GFST and the FRAIL
scale in frailty assessment. It has also a good specificity.
Therefore, it has been shown that the GFST is a valid and
reliable frailty screening tool in the older adults of Turkey.
Living with frailty risk increases with advancing age.
As a result of a review study, the prevalence of frailty
was 10.7% in community-dwelling older adults. [4].
This prevalence rate rises with advancing age [25]. The
geriatric population in the world is climbing.3 As the
geriatric population increases, the truth emerges that the
number of individuals living with frailty rises. This rise
leads to an increase in the number of individuals in need
of care and increases health expenditures [26]. Mortality,
hospitalization, number of hospital admissions, prolonged
length of hospitalization, decrease in quality of life, falls
are more common in patients living with frailty [25, 2729]. With early recognition of frailty and taking necessary
precautions, these adverse health outcomes can be reduced
[30].
Comprehensive geriatric assessment is the best
method for evaluating older adult patients. With the
comprehensive geriatric evaluation; for improving health
outcomes of the patient; functioning, physical health,
cognition, mood, nutritional status, balance, gait speed,
grip strength, medications, bone mineral density, fall
risk, socioeconomic circumstance, chronic diseases of
the patient are examined [31]. Comprehensive geriatric
assessment is of great importance for detecting frailty
and making a care plan. However, CGA is a practice that
takes a long time, which prevents it from being applied
by most physicians [32]. Therefore, practical, easy, and
quick to apply scales have been developed. One of these
is the GFST developed by the geriatric assessment center
called Gérontopôle of Toulouse in France [10]. After the
questions are in the form of a questionnaire without acute
disease and nondependent patients, frailty determination

United Nations. Population Division World Population Prospects 2019 [online]. Website: https://population.un.org/wpp/Download/Standard/Population/ [accessed 31 December 2021].
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Table 1. Demographic and clinical characteristics of patients.
N = 96 (n, %)
Characteristics
Age (median, IQR)

72.0 (10.0)

Sex (female)

59 (61.5)

Illiterate

22 (22.9)

Marital Status (married)

61 (63.5)

Body mass index (mean, SD)

29.19 ± 5.76

Smoking

36 (37.5)

Multimorbidity ≥2

67 (69.8)

Comprehensive geriatric assessment- geriatric syndromes
Dementia

4 (4.2)

Depression

27 (28.1)

Osteoporosis

21 (21.9)

Falls

20 (20.8)

Polypharmacy

50 (52.1)

Drug number (median, IQR)

5.0 (4.0)

Urinary incontinence

39 (40.6)

Katz index of independence in activities of daily living (median, IQR)

6.0 (1.0)

Lawton-Brody instrumental activities of daily living scale (median, IQR)

8.0 (0.0)

Mininutritional assessment-short form (median, IQR)

13.0 (4.0)

Minimental state exam (median, IQR)

28.0 (5.0)

Yesavage geriatric depression scale (median, IQR)

2.0 (6.0)

SARC-F (median, IQR)

1.0 (3.0)

Grip strength(mean, SD)

Females: 17.73 ± 5.02
Males: 27.39 ± 7.41

Gait speed (m/s) (mean, SD)

0.95 ± 0.52

N: number, IQR: interquartile range, SD: standard deviation, m: meter, s: second.

Table 2. Gérontopôle frailty screening tool and reference test concordance results.
Gérontopôle frailty screening tool
Robust

Kappa

p

0.566

<0.001

Frail

The FRAIL scale
Robust

38 (71.7)

6 (14.0)

Prefrail/frail

15 (28.3)

34 (86.0)

Interrater reliability

-

-

0.814

<0.001

Retest reliability

-

-

1.0

<0.001
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is made by the physician’s clinical decision who made the
evaluation. Besides geriatricians, it can be used by general
practitioners and other health professionals because it
does not require a special device, can be done in a short
time and easily [33]. In addition, another positive aspect
of the GFST is that it does not look at frailty from just
one perspective, also guides physicians in terms of social,
physical, and cognitive frailty.
It is of great importance that this frailty screening scale
is used by general practitioners. To recognize communitydwelling frail individuals, general practitioners, who are
the physicians who encounter the geriatric population the
most, need to be aware of frailty. The GFST appears to be
an appropriate tool for GPs and other health professionals
to recognize frailty early and guide the patient for further
evaluation. Thus, it will be possible to reduce the negative
health consequences related to frailty. Validation of the
GFST in more languages will serve this purpose. So far,
there are versions in seven languages.4 As a result of our
study, Turkish validity and reliability were demonstrated.
Turkey is a developing country where the geriatric
population is increasing and will soon be among the aged
countries. In the 2021 data of Turkish Statistical Institute,
the number of individuals aged 65 and over has increased
to 8,245,124, and the ratio has increased to 9.7%.5 This
ratio is expected to be 12.9% in 2030.6 Two studies with
high patient numbers evaluate the frequency of frailty in
Turkey. In the study conducted by Eyigör et al. using the
FRIED frailty index, the prevalence of frail patients was
4

39.2% [34]. The other study was done by Akın et al. that
the Fried frailty index and the FRAIL scale were used. The
frequency of frail participants is 27.8% according to FFI
and 10.0% according to the FRAIL scale [35]. There will
inevitably be an increase in the number of frail individuals
with the prolongation of life expectancy, conditions such
as high illiteracy rate, low socioeconomic level, and rise
in multimorbidities in Turkey. That is why frailty scales
that can be used widely should be validated in the Turkish
population to recognize frailty and intervene early.
Validation of the GFST, which can be used by all healthcare
professionals, has a great significance in this respect.
As a result of this study, it has been shown that the
GFST, which can be used by all healthcare professionals,
is a valid and reliable tool for the Turkish geriatric
population. With the widespread use of the GFST by
health professionals, adverse health outcomes related to
frailty can be reduced.
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